JP2023535025A5 - - Google Patents

Info

Publication number
JP2023535025A5
JP2023535025A5 JP2023504286A JP2023504286A JP2023535025A5 JP 2023535025 A5 JP2023535025 A5 JP 2023535025A5 JP 2023504286 A JP2023504286 A JP 2023504286A JP 2023504286 A JP2023504286 A JP 2023504286A JP 2023535025 A5 JP2023535025 A5 JP 2023535025A5
Authority
JP
Japan
Prior art keywords
nucleic acid
recognition helix
transactivator
dna
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023504286A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535025A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/042949 external-priority patent/WO2022020706A1/en
Publication of JP2023535025A publication Critical patent/JP2023535025A/ja
Publication of JP2023535025A5 publication Critical patent/JP2023535025A5/ja
Pending legal-status Critical Current

Links

JP2023504286A 2020-07-24 2021-07-23 Dna結合ドメイントランス活性化因子およびその使用 Pending JP2023535025A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063056528P 2020-07-24 2020-07-24
US63/056,528 2020-07-24
PCT/US2021/042949 WO2022020706A1 (en) 2020-07-24 2021-07-23 Dna-binding domain transactivators and uses thereof

Publications (2)

Publication Number Publication Date
JP2023535025A JP2023535025A (ja) 2023-08-15
JP2023535025A5 true JP2023535025A5 (cg-RX-API-DMAC7.html) 2024-07-31

Family

ID=79728976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023504286A Pending JP2023535025A (ja) 2020-07-24 2021-07-23 Dna結合ドメイントランス活性化因子およびその使用

Country Status (6)

Country Link
US (1) US20230279405A1 (cg-RX-API-DMAC7.html)
EP (1) EP4185303A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023535025A (cg-RX-API-DMAC7.html)
AR (1) AR123041A1 (cg-RX-API-DMAC7.html)
TW (1) TW202221119A (cg-RX-API-DMAC7.html)
WO (1) WO2022020706A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113710693B (zh) 2019-02-25 2025-07-15 马萨诸塞大学 Dna结合结构域反式激活因子及其用途
WO2024238662A2 (en) * 2023-05-17 2024-11-21 University Of Washington Synthetic nuclear localization signals and methods of their use
WO2025250686A1 (en) * 2024-05-28 2025-12-04 The Regents Of The University Of California Methods and systems for parallel spatially resolved single-cell profiling

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007061759A1 (en) * 2005-11-18 2007-05-31 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Delayed expression vectors
WO2011008260A2 (en) * 2009-07-13 2011-01-20 President And Fellows Of Harvard College Bifunctional stapled polypeptides and uses thereof
EP4600366A3 (en) * 2015-03-31 2025-10-22 SOHM, Inc. Cas 9 retroviral integrase systems for targeted incorporation of a dna sequence into a genome of a cell
EP3443081A4 (en) * 2016-04-13 2019-10-30 Duke University CRISPR / CAS9-BASED REPRESSORS FOR IN VIVO SHUT-OFF OF GEN-TARGETS AND METHOD OF USE
JP7256739B2 (ja) * 2016-09-07 2023-04-12 サンガモ セラピューティクス, インコーポレイテッド 肝臓遺伝子のモジュレーション
JP2018088888A (ja) * 2016-12-06 2018-06-14 国立研究開発法人理化学研究所 Scn1a遺伝子の発現増強法
CN117821509A (zh) * 2017-04-03 2024-04-05 编码治疗公司 组织选择性转基因表达
US20210254056A1 (en) * 2017-05-05 2021-08-19 Camp4 Therapeutics Corporation Identification and targeted modulation of gene signaling networks
CN118345115A (zh) * 2017-12-01 2024-07-16 编码治疗公司 工程化的dna结合蛋白
EP3781174A4 (en) * 2018-04-09 2022-01-26 Allen Institute RESCUE OF VOLTAGE CONTROLLED SODIUM CHANNEL FUNCTION IN INHIBITORY NEURONS
JP7590962B2 (ja) * 2018-11-05 2024-11-27 アレン インスティテュート 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
CN113710693B (zh) * 2019-02-25 2025-07-15 马萨诸塞大学 Dna结合结构域反式激活因子及其用途

Similar Documents

Publication Publication Date Title
JP7832262B2 (ja) 肝特異的ウイルスプロモーター及びその使用方法
US12378576B2 (en) Gene therapy for CNS degeneration
US20210275614A1 (en) Aav triple-plasmid system
JP2022521432A5 (cg-RX-API-DMAC7.html)
WO2020219988A2 (en) Engineering aav
JP2021505133A5 (cg-RX-API-DMAC7.html)
US10016514B2 (en) Polynucleotides, vectors and methods for insertion and expression of transgenes
WO2021242909A1 (en) High throughput engineering of functional aav capsids
JP2023518541A5 (cg-RX-API-DMAC7.html)
JP2022535749A5 (cg-RX-API-DMAC7.html)
JP2024099770A5 (cg-RX-API-DMAC7.html)
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2023542241A5 (cg-RX-API-DMAC7.html)
JP2023535025A (ja) Dna結合ドメイントランス活性化因子およびその使用
JP2022548270A5 (cg-RX-API-DMAC7.html)
US20250206783A1 (en) Transcription-dependent directed evolution of aav capsids having enhanced tropism
JP2024534410A5 (cg-RX-API-DMAC7.html)
CN121399256A (zh) 方法
WO2024218190A1 (en) Generation of adeno-associated virus capsid libraries for insect cells
CN120530197A (zh) 包括星形胶质细胞定向启动子构建体的合成核酸及其使用方法
WO2024050548A2 (en) Compact promoters for targeting hypoxia induced genes
RU2021133872A (ru) Модуляторы экспрессии гена открытой рамки считывания 72 хромосомы 9 и их применения